COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease

R Fernandez-Ruiz, JL Paredes, TB Niewold - Translational Research, 2021 - Elsevier
As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

The role of pharmaceutical compounding in promoting medication adherence

M Carvalho, IF Almeida - Pharmaceuticals, 2022 - mdpi.com
Pharmaceutical compounding is an important component of pharmacy practice despite its
low prevalence. Several therapeutic needs can be met by a compounded medicine such as …

Let's do better: public representations of COVID-19 science

T Caulfield, T Bubela, J Kimmelman, V Ravitsky - Facets, 2021 - facetsjournal.com
COVID science is being both done and circulated at a furious pace. While it is inspiring to
see the research community responding so vigorously to the pandemic crisis, all this activity …

Self medication practices and its determinants in health care professionals during the coronavirus disease-2019 pandemic: cross-sectional study

OC Okoye, OA Adejumo, AO Opadeyi… - International journal of …, 2022 - Springer
Background The exposure of health care professionals (HCP) to patients with coronavirus
disease-2019 (COVID-19) in the course of performing their professional duties may expose …

Antirheumatic disease therapies for the treatment of COVID‐19: a systematic review and meta‐analysis

M Putman, YPE Chock, H Tam, AHJ Kim… - Arthritis & …, 2021 - Wiley Online Library
Objective Antirheumatic disease therapies have been used to treat coronavirus disease
2019 (COVID‐19) and its complications. We conducted a systematic review and meta …

Utilisation, availability and price changes of medicines and protection equipment for COVID-19 among selected regions in India: findings and implications

M Haque, S Kumar, J Charan, R Bhatt… - Frontiers in …, 2021 - frontiersin.org
Background: COVID-19 has already claimed a considerable number of lives worldwide.
However, there are concerns with treatment recommendations given the extent of conflicting …

Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International …

A Mendel, S Bernatsky, A Askanase, SC Bae… - Annals of the …, 2021 - ard.bmj.com
Early scientific and public enthusiasm for hydroxychloroquine (HCQ) as a potential therapy
for COVID-19 has prompted over 100 registered trials to date, although its efficacy remains …

Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases

JS Hausmann, K Kennedy, JF Simard… - The Lancet …, 2021 - thelancet.com
Background The impact and consequences of the COVID-19 pandemic on people with
rheumatic disease are unclear. We developed the COVID-19 Global Rheumatology Alliance …

Mental health and quality of life for people with rheumatoid arthritis or ankylosing spondylitis in Aotearoa New Zealand following the COVID-19 national lockdown

G Johnstone, GJ Treharne, BD Fletcher… - Rheumatology …, 2021 - Springer
The aim of this study was to investigate the effects of lockdown on the mental health (anxiety
and depression) and quality of life (QOL) of people with rheumatoid arthritis (RA) and …

Rise and fall: hydroxychloroquine and COVID‐19 global trends: interest, political influence, and potential implications

TR Englund, AC Kinlaw, SZ Sheikh - ACR Open Rheumatology, 2020 - Wiley Online Library
Objective The coronavirus disease 2019 (COVID‐19) pandemic has led to rapid research
and reporting on potential preventatives and treatments for the disease, including the drug …